{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:52:17Z","timestamp":1761519137702},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T00:00:00Z","timestamp":1448841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40618-015-0412-6","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T05:37:36Z","timestamp":1448861856000},"page":"349-354","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mild primary hyperparathyroidism as defined in the Italian Society of Endocrinology\u2019s Consensus Statement: prevalence and clinical features"],"prefix":"10.1007","volume":"39","author":[{"given":"E.","family":"Castellano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gianotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"key":"412_CR1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40618-015-0261-3","volume":"38","author":"C Marcocci","year":"2015","unstructured":"Marcocci C, Brandi ML, Scillitani A, Corbetta S, Faggiano A, Gianotti L, Migliaccio S, Minisola S (2015) Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J Endocrinol Invest 38:577\u2013593","journal-title":"J Endocrinol Invest"},{"key":"412_CR2","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99:3561\u20133569","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-11-0589","volume":"165","author":"J Bollerslev","year":"2011","unstructured":"Bollerslev J, Marcocci C, Sosa M, Nordenstrom J, Bouillon R, Mosekilde L (2011) Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur J Endocrinol 165:851\u2013864","journal-title":"Eur J Endocrinol"},{"key":"412_CR4","first-page":"2036","volume":"8","author":"SJ Silverberg","year":"1996","unstructured":"Silverberg SJ, Bilezikian JP (1996) Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 8:2036\u20132040","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR5","unstructured":"(1990) Diagnosis and management of asymptomatic primary hyperparathyroidism. National Institutes of Health Consensus Development Conference. Consens Statement 8:1\u201318"},{"key":"412_CR6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.14310\/horm.2002.1581","volume":"14","author":"R Sklavenitis-Pistofidis","year":"2015","unstructured":"Sklavenitis-Pistofidis R, Papaioannou O, Kotsa K (2015) Primary hyperparathyroidism and the road to surgery: appraisal of the proceedings of the four international workshops (1990, 2002, 2008, 2014) on primary hyperparathyroidism. Hormones (Athens) 14:201\u2013210","journal-title":"Hormones (Athens)"},{"key":"412_CR7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jc.2011-2107","volume":"97","author":"S Iwata","year":"2012","unstructured":"Iwata S, Walker MD, Di Tullio MR, Hyodo E, Jin Z, Liu R, Sacco RL, Homma S, Silverberg SJ (2012) Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab 97:132\u2013137","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Wermers","year":"2006","unstructured":"Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ III (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease. J Bone Min Res 21:171\u2013177","journal-title":"J Bone Min Res"},{"key":"412_CR9","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","volume":"67","author":"DS Rao","year":"1988","unstructured":"Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM (1988) Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294\u20131298","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR10","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev J, Jansson S, Mollerup CL, Nordenstr\u00f6m J, Lundgren E, T\u00f8rring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687\u20131692","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ando.2015.03.001","volume":"76","author":"DP Macfarlane","year":"2015","unstructured":"Macfarlane DP, Yu N, Leese GP (2015) Asymptomatic and mild primary hyperparathyroidism. Ann Endocrinol (Paris) 76:120\u2013127","journal-title":"Ann Endocrinol (Paris)"},{"key":"412_CR12","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","volume":"94","author":"E Vignali","year":"2009","unstructured":"Vignali E, Viccica G, Diacinti D, Cetani F, Cianferotti L, Ambrogini E, Banti C, Del Fiacco R, Bilezikian JP, Pinchera A, Marcocci C (2009) Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 94:2306\u20132312","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","volume":"100","author":"C Cipriani","year":"2015","unstructured":"Cipriani C, Biamonte F, Costa AG, Zhang C, Biondi P, Diacinti D, Pepe J, Piemonte S, Scillitani A, Minisola S, Bilezikian JP (2015) Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J Clin Endocrinol Metab 100:1309\u20131315","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4158\/EP14074.OR","volume":"20","author":"S Cassibba","year":"2014","unstructured":"Cassibba S, Pellegrino M, Gianotti L, Baffoni C, Baralis E, Attanasio R, Guarnieri A, Borretta G, Tassone F (2014) Silent renal stones in primary hyperparathyroidism: prevalence and clinical features. Endocr Pract 20:1137\u20131142","journal-title":"Endocr Pract"},{"key":"412_CR15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-13-0502","volume":"169","author":"C Blanchard","year":"2013","unstructured":"Blanchard C, Mathonnet M, Sebag F, Caillard C, Hamy A, Volteau C, Heymann MF, Wyart V, Drui D, Roy M et al (2013) Surgery for \u2018asymptomatic\u2019 mild primary hyperparathyroidism improves some clinical symptoms postoperatively. Eur J Endocrinol 169:665\u2013672","journal-title":"Eur J Endocrinol"},{"key":"412_CR16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","volume":"16","author":"SJ Silverberg","year":"2013","unstructured":"Silverberg SJ, Walker MD, Bilezikian JP (2013) Asymptomatic primary hyperparathyroidism. J Clin Densitom 16:14\u201321","journal-title":"J Clin Densitom"},{"key":"412_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4137\/CMED.S13147","volume":"6","author":"C Eufrazino","year":"2013","unstructured":"Eufrazino C, Veras A, Bandeira F (2013) Epidemiology of primary hyperparathyroidism and its non-classical manifestations in the City of Recife, Brazil. Clin Med Insights Endocrinol Diabetes 6:69\u201374","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"412_CR18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.otc.2004.02.007","volume":"37","author":"TF Saleem","year":"2004","unstructured":"Saleem TF, Horwith M, Stack BC Jr (2004) Significance of primary hyperparathyroidism in the management of osteoporosis. Otolaryngol Clin North Am 37:751\u2013761","journal-title":"Otolaryngol Clin North Am"},{"key":"412_CR19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1634\/theoncologist.2011-0285","volume":"17","author":"K Wood","year":"2012","unstructured":"Wood K, Dhital S, Chen H, Sippel RS (2012) What is the utility of distal forearm DXA in primary hyperparathyroidism? Oncologist 17:322\u2013325","journal-title":"Oncologist"},{"issue":"Suppl 17","key":"412_CR20","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1681\/ASN.V12suppl_1s3","volume":"12","author":"R Ziegler","year":"2001","unstructured":"Ziegler R (2001) Hypercalcemic crisis. J Am Soc Nephrol 12(Suppl 17):S3\u2013S9","journal-title":"J Am Soc Nephrol"},{"key":"412_CR21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40618-014-0056-y","volume":"37","author":"MS Rathi","year":"2014","unstructured":"Rathi MS, Gonzalez S, Wright D, Ellis NR, Peacey SR (2014) Management of hypovitaminosis D in patients with primary hyperparathyroidism. J Endocrinol Invest 37:467\u2013471","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0412-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0412-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0412-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T17:56:33Z","timestamp":1653674193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0412-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0412-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,30]]}}}